Sirtex Medical Limit
SRX
End-of-day quote AUSTRALIAN SECURITIES EXCHANGE LIMITED - 07/19
32.07AUD
-0.09%
Prev.32.1000
Open32.1000
High32.1300
Low32.0500
Volume482 085
Financials
Sales 2018 224 M
EBIT 2018 73,0 M
R. net 2018 56,3 M
Tréso. 2018 110 M
Rend. 2018 0,91%
P/E ratio 2018 33,22
P/E ratio 2019 29,57
EV / Sales 2018 7,49x
EV / Sales 2019 6,75x
Capitalization 1 790 M
Company
Sirtex Medical Ltd. engages in the research, commercial development, manufacture, and distribution of liver cancer treatments.It offers targeted radiation therapy known as SIR-Spheres Y-90 resin microspheres.Its clinical programs include SIRFLOX, FOXFIRE/FOXFIRE Global, SARAH, SIRveNIB, and SORAMIC.
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2018-08-29 Earnings Release
Trading Rating :
Investor Rating :
Latest news
07/05CHINA GRAND PHA AND HEALTHCARE HLD : Pharm (512) to raise HK$2.88bn from rights issue
AQ
06/20GLOBAL CARCINOID SYNDROME MANAGEMENT MARKET GROWTH ANALYSIS, SHARE, DEMAND BY REGIONS, TYPES AND ANALYSIS OF KEY PLAYERS- RESEARCH FORECASTS TO 2023 : The research provide Industry Overview, Market history, Market competition, Development and Trades and Trade policies. The research provide investment analysis opportunities market shares profiling top key players Novartis International AG (Sandoz), Pharmascience Inc., Omega Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Mylan NV, Ipsen
AQ
06/16CHINA GRAND PHA AND HEALTHCARE HLD : Pharm & partner to buy Sirtex at AUD1.9bn
AQ
05/23China Grand Pharm may participate in Sirtex Medical buy
AQ
05/07VARIAN MEDICAL : Notes Receipt of Competing Bid by Sirtex
AQ
05/04Chinese firm makes last-minute $1.4 billion offer for Australia's Sirtex, trumps Varian
RE
02/16SIRTEX MEDICAL LIMITED : half-yearly earnings release
02/09VARIAN MEDICAL : Norton Rose Fulbright Advises Medtech Giant Varian on AU$1.58bn Acquisition of Sirtex
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance33,136,240,1
Spread/Res.-3,1%-11%-20%
Spread/Supp.4,1%41%61%
Support30,822,720,0